找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: 30th Hemophilia Symposium Hamburg 1999; HIV Infection and Ep Inge Scharrer,Wolfgang Schramm Conference proceedings 2001 Springer Verlag Ber

[復制鏈接]
樓主: 強烈興趣
31#
發(fā)表于 2025-3-26 21:46:12 | 只看該作者
32#
發(fā)表于 2025-3-27 02:51:23 | 只看該作者
33#
發(fā)表于 2025-3-27 09:03:10 | 只看該作者
Functional Consequences of Differences in Carbohydrate Sequences of Fetal and Adult Plasminogen and ge stakeholders’ needs — technical, financial, legal, and environmental aspects, customer requirements, Corporate strategy, etc. -, being a multidisciplinary and strategic issue. An approach to use real option to support the decision-making process at PDP phases in taken. The real option valuation m
34#
發(fā)表于 2025-3-27 10:07:56 | 只看該作者
Hereditary Thrombophilic Risk Profiles in Children with Spontaneous Venous Thromboembolismms design is reused and customized to meet diverse customer requirements such as application, cost, and operational considerations. Many of these dynamic changes in nature have required system design component variations referred to as “variants” on top of a fixed master design. One approach to real
35#
發(fā)表于 2025-3-27 17:30:16 | 只看該作者
Inhibitor Development in Previously Untreated Patients with Hemophilia A and B: A Prospective 23-Yean & Management" (CSDM 2014) international conference held in.?This book contains all refereed papers that were accepted to the fifth edition of the ? Complex Systems Design & Management ? (CSD&M 2014) international conference which took place in Paris (France) on the November 12-14, 2014..These proc
36#
發(fā)表于 2025-3-27 21:25:49 | 只看該作者
dern treatment of hemophilia, drug-induced thrombophilia and pediatric hemostasiology. The volume is rounded off by numerous free papers and posters on hemophilia and associated topics.978-3-540-67677-5978-3-642-18240-2
37#
發(fā)表于 2025-3-27 23:44:25 | 只看該作者
38#
發(fā)表于 2025-3-28 04:51:01 | 只看該作者
39#
發(fā)表于 2025-3-28 09:49:31 | 只看該作者
How to Set Things Up? Study Designs,III; substitution by exogenous factor VIII concentrates is the main form of medical treatment. In Germany, about 5800 patients are affected; the average cost for the treatment is about 100,000 DM per patient per year, totaling more than 500 million DM per year. Worldwide, only 20% of patients can be treated because of the expense of the therapy.
40#
發(fā)表于 2025-3-28 11:15:15 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 19:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
灌云县| 揭阳市| 准格尔旗| 大丰市| 会理县| 凉山| 恩平市| 湖北省| 东光县| 阿巴嘎旗| 大城县| 正定县| 莎车县| 西昌市| 邛崃市| 海阳市| 沂水县| 庆安县| 清水河县| 老河口市| 宁国市| 合作市| 沂水县| 简阳市| 剑川县| 中西区| 保靖县| 清镇市| 句容市| 苏州市| 新余市| 库尔勒市| 江永县| 上虞市| 甘泉县| 都江堰市| 循化| 惠州市| 游戏| 渑池县| 山西省|